A recent opposition decision by the New Zealand Patent Office in Resmed Pty Ltd v Fisher & Paykel Healthcare Limited [2026] NZIPOPAT 6 provides a useful reminder of how divisional patent practice in New Zealand differs from that in Australia, and the traps unsuspecting applicants can fall into in both jurisdictions.While not the substance of the Resmed decision, the Assistant Commissioner